{
  "thread": {
    "uuid": "01dacd6f96ab468433e3cb317eb924a373a613df",
    "url": "https://www.openpr.com/news/4127371/next-generation-iv-infusion-pumps-market-to-hit-us-5-58-bn",
    "site_full": "www.openpr.com",
    "site": "openpr.com",
    "site_section": "https://openpr.com/news/kategorien2-19-consumer-goods-retail.html",
    "site_categories": [
      "marketing",
      "financial_news",
      "finance",
      "business"
    ],
    "section_title": "openPR.com - ",
    "site_title": "openPR.com - Worldwide Open Public Relations - Publish Press Releases Free of Charge",
    "title": "Next-Generation IV Infusion Pumps Market to Hit US$ 5.58 Bn",
    "title_full": "Next-Generation IV Infusion Pumps Market to Hit US$ 5.58 Bn",
    "published": "2025-07-31T08:11:38.066+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://cdn.open-pr.com/L/7/L731725767_g.jpg",
    "performance_score": 0,
    "domain_rank": 8956,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "01dacd6f96ab468433e3cb317eb924a373a613df",
  "url": "https://www.openpr.com/news/4127371/next-generation-iv-infusion-pumps-market-to-hit-us-5-58-bn",
  "ord_in_thread": 0,
  "author": "Persistence Market Research",
  "published": "2025-07-31T08:11:38.066+03:00",
  "title": "Next-Generation IV Infusion Pumps Market to Hit US$ 5.58 Bn",
  "text": "Next-Generation IV Infusion Pumps Market to Hit US$ 5.58 Bn by 2032, Says Persistence Market Research 07-31-2025 06:55 AM CET | Health & Medicine\nPress release from: Persistence Market Research Next-Generation IV Infusion Pumps Market\nAdvancing precision, safety, and digital integration, next-generation IV infusion pumps are revolutionizing acute and chronic patient care across the globe. According to Persistence Market Research, worldwide revenue from the next-generation IV infusion pumps market is projected to rise from approximately US$3.4 billion in 2025 to nearly US$5.6 billion by 2032, registering a robust CAGR of 8.3%. This growth is propelled by a convergence of technological innovation, a mounting chronic disease burden, and demand for efficient, error-minimizing drug delivery systems.\nHospitals, ambulatory facilities, and home healthcare settings are rapidly adopting these sophisticated pumps, which feature advanced software and connectivity. Persistence Market Research notes that large volumetric infusion systems lead the segment, with North America and key Asian markets spearheading adoption. This in-depth report explores the market's drivers, restraints, segmentation nuances, opportunities, and the competitive landscape shaping the future of IV drug delivery.\n✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/15781\n✅Market Overview, Statistics, and Key Drivers\nNext-generation IV infusion pumps are computer-controlled devices that ensure precise delivery of fluids, nutrients, or medications to patients over prescribed intervals. What sets them apart from older models is their integration with smart features-dose error reduction systems (DERS), drug libraries, automated alarms, and real-time data sharing. These pumps sharply reduce the risk of adverse drug events, now a key focus area for health providers and regulators globally.\nDriven by rapid increases in chronic illnesses (diabetes, cancer, heart failure), the global market is expected to grow at 8.3% CAGR from 2025 to 2032. Hospitals remain the largest buyers, but adoption is surging in home care and ambulatory surgical centers, responding to the demand for portable, reliable, and connected care devices. North America leads in both technology innovation and procurement due to advanced infrastructure and regulatory focus on device safety and interoperability. Meanwhile, large volumetric infusion systems are the top-selling segment for their versatility and safety, accounting for over a third of total revenues.\nThe fundamental growth drivers include surging admissions of patients with chronic diseases requiring complex infusions, rising surgical volumes, population aging, and technological leaps in medtech. Digital transformation, wireless connectivity, and telehealth compatibility position next-generation infusion pumps as a linchpin in modern healthcare delivery.\n✅Key Highlights from the Report:\n➤ Next-generation IV infusion pumps market to value US$5.6 billion by 2032, growing at 8.3% CAGR from 2025.\n➤ Large volumetric infusion systems are leading the segment, prized for versatility and precise administration.\n➤ North America remains the top region by market share, driven by advanced healthcare and regulatory push.\n➤ China dominates East Asia, spurred by rising cancer prevalence and modernization of hospital infrastructure.\n➤ Portable and ambulatory infusion pumps are gaining momentum for home healthcare and chronic disease management.\n➤ Industry innovation centers around smart technology integration, miniaturization, wireless features, and AI-driven safety advancements.\n✅Market Segmentation\n✅By Product Type\nThe market covers a range of infusion systems:\nLarge volumetric infusion pumps: The largest category, delivering precise volumes for critical care, surgery, and complex therapies.\nSyringe pumps: Used for highly accurate, low-volume infusions-common in ICUs, pediatric, and oncology settings.\nAmbulatory/portable infusion pumps: Designed for home care and patient mobility, favored in diabetes, cancer, and palliative treatments.\nElastomeric pumps, disposable pumps, and smart enteral pumps: Expanding for specialized and niche therapies, easing workflow and infection control.\nSmart pumps equipped with integrated drug libraries, barcode scanning, closed-loop communication, and remote monitoring dominate new procurement and upgrade cycles.\n✅By End-User\nHospitals: The principal buyers, given their need for high-volume, multifunctional devices supporting acute care, surgery, and emergencies.\nAmbulatory surgical centers: Increasingly adopting pumps for perioperative medication delivery, anesthesia, and pain control.\nHome healthcare & long-term care: Demand is rising rapidly as chronic diseases and post-acute care shift out of hospital.\nClinics, specialty care, and diagnostic centers: Simpler, portable pumps are expanding in smaller facilities offering infusion or short-term treatments.\nSmart connectivity and drug safety features are particularly valued in hospitals, while portability, ease of use, and cost drive preferences in out-of-hospital settings.\n✅Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/next-generation-iv-infusion-pumps-market.asp\n✅Regional Insights\nNorth America\nNorth America commands the largest share, led by the United States which accounts for nearly 85% of the regional market share. Growth drivers include high rates of chronic illness, aggressive digital health policies, early FDA-approved smart pump technologies, and strong reimbursement frameworks. Major device recalls and the FDA's ongoing Infusion Pump Improvement Initiative (since 2010) continue to push manufacturers toward safer, more transparent devices. The dominance of top global suppliers-Medtronic, B. Braun, Baxter, BD, Smiths Medical-exerts a strong influence on adoption and innovation.\nEurope\nEurope is propelled by a high prevalence of chronic diseases, an aging population, and advanced hospital systems. Germany leads the continent for IV infusion pump demand due to a large elderly cohort, high healthcare spending, and world-class engineering. EU-wide harmonization of device standards, stringent regulatory oversight, and increasing push for home-based care will further drive regional growth.\nAsia Pacific\nAsia Pacific, led by China and Japan, is the fastest-growing region. China accounts for over half the East Asian market due to rising cancer incidence, the massive hospital upgrade drive, and growing awareness of digital health tools. Japan's tech-savvy medical sector also ensures rapid adoption, especially in tertiary and teaching hospitals.\nOther Regions\nLatin America, the Middle East, and Africa show promise as investments in hospital digitalization, new care models, and health system modernization fund the procurement of next-generation devices-especially in Brazil, South Africa, Saudi Arabia, and India.\n✅Category-Wise Insights\nLarge Volumetric Infusion Systems: Dominate due to broad utility, safety, and advanced delivery controls.\nSyringe & Ambulatory Pumps: Winning share in pediatric, oncology, outpatient, and homecare settings.\nPain Management, Chemotherapy, and Parenteral Nutrition: These applications top demand, driven by the global burden of chronic pain and cancer.\n✅Market Drivers\nNext-generation IV infusion pumps are accelerated by:\nRising chronic disease burden: The global surge in diabetes, cancer, and pain disorders necessitates precision, programmable infusions.\nShift to homecare and ambulatory settings: COVID-19 and value-based care are fueling demand for portable, wireless, and patient-centric pumps.\nSmart technology integration: Dose error reduction software (DERS), automated drug libraries, and EHR interoperability minimize medication errors and drive procurement.\nAging population: The rising number of elderly patients requiring long-term infusion therapy is a key market expansion driver.\n✅Market Restraints\nThe market faces notable headwinds:\nDevice errors, recalls, and design complexity: Despite progress, smart pumps can suffer from UI/software glitches, programming errors, power failures, and user/workflow challenges leading to adverse events.\nStringent regulatory hurdles: Gaining FDA or CE approval for new features is resource-intensive and can slow innovation and introduction.\nCybersecurity risks: As devices become more connected, vulnerability to cyber-attacks (altered dosing, data breaches) poses new risks, requiring continuous investment in digital security.\nCost barriers: High upfront investments limit adoption in resource-constrained environments.\n✅Market Opportunities\nThe next five years offer major growth avenues:\nExpansion in low- and middle-income markets: Investments in health infrastructure and digitization promise rapid growth in Asia Pacific, Latin America, and Africa.\nDevelopment of miniaturized, wearable, and disposable pumps: R&D into easy-to-use, cost-effective systems for outpatient and home use will broaden access.\nIntegration with AI and remote monitoring: Pumps using artificial intelligence to predict errors or stop infusions, and those connected to cloud/EHR platforms, will transform care.\nMergers, partnerships, and new entrants: Collaboration drives innovation; partnerships with software, health IT, and drug companies will fuel smarter, safer solutions.\n✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/15781\n✅Reasons to Buy the Report\n✔ In-depth segmentation by device, application, technology, and region for targeted strategy.\n✔ Up-to-date competitive intelligence-including innovation mapping, mergers, and recent product launches.\n✔ Regulatory insights and market access dynamics across regions.\n✔ Actionable opportunities in ambulatory, home care, and emerging market segments.\n✔ Full pipeline analysis for AI-enabled and wireless infusion pump developments.\n✅Company Insights\n✦ Gamastech S.R.L\n✦ Ambu A/S\n✦ Summit Medical Products, Inc.\n✦ Nipro Corporation\n✦ Terumo Corporation\n✦ Medtronic Plc.\n✦ Zyno Medical\n✦ Baxter International Inc.\n✦ Fresenius Kabi AG\n✦ B. Braun Melsungen AG\n✦ Becton, Dickinson Company (CareFusion)\n✦ Smiths Medical (Smiths Group plc)\n✦ Hospira Inc.\n✦ iRadimed Corporation\n✦ vTitan\n✅Recent Developments:\nIn February 2021, B. Braun Medical's Infusomat® Space® Large Volume Pump was named best in KLAS for Traditional Smart Pumps, reflecting industry leadership in quality and innovation.\nIn June 2019, Ivenix received FDA approval for a new infusion system designed to enhance safety and address persistent issues in conventional pump technology.\n✅Conclusion\nThe next-generation IV infusion pumps market is at a pivotal intersection of advanced technology, patient safety, and healthcare digitalization. Persistence Market Research underscores how the global shift to value-based, patient-centric care will make these devices essential to hospitals, ambulatory providers, and home health agencies over the next decade. With innovation, regulatory focus, and the expansion of wireless, AI-driven pumps, stakeholders who invest now in next-generation technologies stand to gain from both improved patient outcomes and sustainable market leadership through 2032 and beyond.\nContact Us:\nPersistence Market Research\nG04 Golden Mile House, Clayponds Lane\nBrentford, London, TW8 0GU UK\nUSA Phone: +1 646-878-6329\nUK Phone: +44 203-837-5656\nEmail: sales@persistencemarketresearch.com\nWeb: https://www.persistencemarketresearch.com\nAbout Persistence Market Research:\nAt Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.\nOur approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.\nThis release was published on openPR.",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Economy, Business and Finance",
    "Science and Technology"
  ],
  "topics": [
    "Health->health organisation",
    "Health->health treatment and procedure",
    "Health->medical service",
    "Economy, Business and Finance->products and services",
    "Economy, Business and Finance->healthcare industry",
    "Science and Technology->medical research",
    "Science and Technology->biotechnology"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [
    "https://opr.li/com/85f5573ad91869aeb312dd75461c65a3/",
    "https://www.persistencemarketresearch.com/market-research/next-generation-iv-infusion-pumps-market.asp",
    "https://opr.li/com/f6095fc01a37ceadbffbe48e17b80f14/",
    "https://www.persistencemarketresearch.com",
    "https://www.persistencemarketresearch.com/request-customization/15781",
    "https://opr.li/com/ed1ed7f215757183a2bc201ae55e0f3f/",
    "https://opr.li/com/3b1846aee805180a793db378a183e2cd/",
    "https://www.persistencemarketresearch.com/samples/15781",
    "https://persistencemarketresearch.com/samples/15781",
    "https://persistencemarketresearch.com/market-research/next-generation-iv-infusion-pumps-market.asp",
    "https://www.opr.li/com/85f5573ad91869aeb312dd75461c65a3/",
    "https://persistencemarketresearch.com",
    "https://opr.li/com/f6095fc01a37ceadbffbe48e17b80f14",
    "https://www.opr.li/com/3b1846aee805180a793db378a183e2cd/",
    "https://opr.li/com/85f5573ad91869aeb312dd75461c65a3",
    "https://www.opr.li/com/f6095fc01a37ceadbffbe48e17b80f14/",
    "https://opr.li/com/3b1846aee805180a793db378a183e2cd",
    "https://www.opr.li/com/ed1ed7f215757183a2bc201ae55e0f3f/",
    "https://opr.li/com/ed1ed7f215757183a2bc201ae55e0f3f",
    "https://persistencemarketresearch.com/request-customization/15781"
  ],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [
      {
        "name": "North",
        "sentiment": "none"
      }
    ],
    "organizations": [
      {
        "name": "Persistence Market Research",
        "sentiment": "none",
        "tickers": []
      }
    ]
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2025-07-31T08:11:38.066+03:00",
  "updated": "2025-07-31T08:17:43.000+03:00"
}